News | April 20, 2026
Pharma stocks face Q4 reality check amid global headwinds
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Move to accelerate cancer care expansion across India
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
